Skip to main content
CODX logo

CODX · Co-Diagnostics, Inc. · Share Buybacks

Track CODX — free
$0.26 -0.01 (-4.12%) At close · Nov 13 Play latest call Q2 2026 earnings call transcript
Market Cap
$2.72M
Shares
10.51M
Volume · Nov 13 591.94K Avg daily vol (3M) 1.97M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$30,000,000
as of 2022-03-01 · from 10-Q (reviewed)

Repurchase Programs

Program Announced Authorized Remaining Runs Through
2022-03-01 $30,000,000 — —

Equity Offering (ATM) Programs

Program Established Capacity Remaining Runs Through
2025-10-20 $7,901,383 $7,350,878 as of 2026-10-07 —

Cash spent on buybacks by quarter

Cash deployed each quarter, with the average price paid where the company reported it (on today's share basis). Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended Cash Spent
2023-12-31 $1,363,929
2022-12-31 $14,211,866

Share counts and average prices are restated onto today's share basis across later stock splits; cash spent is as reported. ‡ marks a row kept as filed because a later split could not be attributed to this stock's shares.

Key facts CIK 1692415 CUSIP 189763204 13F (30d) 30 filings 20 filers Visit website Investor relations